Remdesivir is said to be delivered by drug control officers


Government. issues SOP for private hospitals to resolve bottlenecks

To streamline supplies of remdesivir, a vital drug in the treatment of moderate to severe COVID-19 cases, the state government has passed a Standard Operating Procedure (SOP) to regulate their supply through the Assistant Director (AD) of Drug Control in all Cases to direct circle.

Visakhapatnam has had a severe shortage of remdesivir for a week and black marketeers have flourished during this time. The district is facing a shortage of at least 40%, health officials say.

The issue was taken up with the Minister of Health and the Chief Secretary for Health, and it was decided that starting Monday, all private hospitals registered under Categories A and B to treat COVID-19 cases will create a direct debit for Remdesivir with the AD on a daily basis and this will consolidate the indents and forward them to the Director General (DG) for Drug Control at the end of the day, said collector V. Vinay Chand.

The GD will place the demand with hetero drugs, the manufacturers, and the supply to the districts will be directed through the GD.

This is expected to address the shortage of private hospitals while there is no such problem in state hospitals, Vinay Chand said.

On the other hand, the unregistered hospitals treating COVID patients can contact the DMHO and register in one of the categories and then place their indentation for the drug, “said Dr. PV Sudhakar, Director of Andhra Medical College.

However, health officials are concerned about the amount of supply. There is currently a demand in the state for around 30,000 to 40,000 vials per day and the supply is around 15,000, a senior official said.

Not surgical drug

Dr. Balaraju, a senior pulmonologist, stated that remdesivir cannot be bought over the counter: “Remdesivir cannot be given at home or to patients in isolation at home. It is not a surgical drug (outpatient). “

Remdesivir is given to patients whose oxygen saturation falls below 95% and who are hospitalized with symptoms of hypoxia or dyspnoea or other complications. It is given to patients in the hospital with moderate to severe illness, said Dr. Sudhakar.


Please enter your comment!
Please enter your name here